Bruker Posts 16-Percent Rise in Q1 Revenue Atop R&D and Profit Growth | GenomeWeb
NEW YORK (GenomeWeb News) — Bruker BioSciences today said first-quarter revenues increased 16 percent as R&D spending rose 11 percent and profit grew 19 percent.
Total receipts for the three months ended March 31 increased to $110.5 million from $94.9 million year over year.
Product revenue increased 14 percent to $95.4 million; service revenue increased 43 percent to $15 million; and “other” revenue contracted 76 percent to $154,000.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.